Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Antharis Therapeutics, Inc. logo — Antharis Therapeutics is a multinational biopharmaceutical c...

Antharis Therapeutics, Inc.

Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting-edge treatments for cancer.

Founded 2020 United States San Diego, United States 18 employees Biopharma, Biotechnology +1

General Information

Company Name Antharis Therapeutics, Inc.
Founded Year 2020
Location United States San Diego, United States
Founders / Decision Makers
Team member
Employees 18
Industries Biopharma, Biotechnology, Health and Wellness
Business Model B2B
Revenue Model Licensing, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Antharis Therapeutics, Inc.. To contact Antharis Therapeutics, Inc., visit antharistherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Antharis Therapeutics, Inc. compare?

A PDF of Antharis Therapeutics, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Antharis Therapeutics, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Antharis Therapeutics, Inc.

Antharis Therapeutics, Inc., founded in 2020 by Dr. Raphael R Pinaud, is a multinational biopharmaceutical company headquartered in the United States. Specializing in cancer and inflammatory disease treatments, it employs cutting-edge science to create next-generation monoclonal antibodies and antibody-drug conjugates.

In mid-2022 and mid-2023, Antharis strategically acquired Cassyni Biopharma and Galileo Biotech, respectively, bolstering its capabilities. These acquisitions have enhanced its pipeline of innovative therapies, positioning it to address unmet medical needs effectively.

With plans to initiate clinical trials in 2025, Antharis is making notable progress in its mission to deliver transformational cancer treatments. Despite having no information on its last investment, the company remains an appealing opportunity for investors seeking to make an impact in the thriving biopharma and biotechnology sectors.

Business keywords: biopharmaceutical, cancer treatment, monoclonal antibodies, antibody-drug conjugates, oncology, therapeutic antibodies, inflammatory diseases, innovative therapies, biotech acquisitions, clinical trials, transformational therapies, unmet medical needs, pioneering research, solid tumor therapy, bispecific antibodies

Services & Products

Developing Transformative Medicines
Therapies Harnessing the Immune System
Cutting-edge Biomedical Research
Therapeutically-relevant Antibody Development

Target Customers

Healthcare Professionals Patients with Unmet Medical Needs Cancer Patients Medical Institutions Biotech and Pharmaceutical Partners

No funding data available for Antharis Therapeutics, Inc. yet.

Antharis Therapeutics, Inc. Alternatives & Competitors

View All Alternatives
Antharis Therapeutics, Inc. vs
FatiAbGen Inc.
FatiAbGen Inc. Korea South

Best in class multi-modality antibodies for difficult targets in high unmet need diseases in oncolog...

Seed
9 employees
Biopharma, Biotechnology
Antharis Therapeutics, Inc. vs
Mestag Therapeutics
Mestag Therapeutics United Kingdom

New therapies for inflammatory disease and cancer by targeting fibroblast immunology

Seed
40 employees
Biotechnology, Health Care
Antharis Therapeutics, Inc. vs
Asylia Therapeutics
Asylia Therapeutics

Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious diseases.

Series A
1 employees
Biotechnology, Health Care
Also compare with: Antharis Therapeutics, Inc. vs Mabwell Mabwell Antharis Therapeutics, Inc. vs Harbour BioMed Harbour BioMed Antharis Therapeutics, Inc. vs ImmunoBiochem Corporation ImmunoBiochem Corporation View all alternatives

FAQ About Antharis Therapeutics, Inc.

Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting-edge treatments for cancer.
Antharis Therapeutics, Inc. was founded in 2020.
Antharis Therapeutics, Inc. is headquartered in San Diego, United States.
Antharis Therapeutics, Inc. operates in Biopharma, Biotechnology and Health and Wellness. Its work centres on biopharmaceutical, cancer treatment, monoclonal antibodies and antibody-drug conjugates. Its customers include Healthcare Professionals, Patients with Unmet Medical Needs and Cancer Patients.
Antharis Therapeutics, Inc. has a B2B business model. Its revenue comes from Licensing and Product Sales.
Antharis Therapeutics, Inc. has approximately 18 employees.
Antharis Therapeutics, Inc. offers: Developing Transformative Medicines, Therapies Harnessing the Immune System, Cutting-edge Biomedical Research, Therapeutically-relevant Antibody Development.
Top alternatives and competitors to Antharis Therapeutics, Inc. include FatiAbGen Inc., Mestag Therapeutics, Asylia Therapeutics, Pheon Therapeutics, Avenzo Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Antharis Therapeutics, Inc. and FatiAbGen Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Antharis Therapeutics, Inc., https://bouncewatch.com/company/antharis-therapeutics, updated 27 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes